Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Basic Science

First assessment of [18F]-FMH3 in human, a selective histamine H3 receptor PET tracer

Gilles Tamagnan, Olivier Barret, David Alagille, Terence Hamill, Ronald Baldwin, Andrei Koren, David Russell, Danna Jennings, Kenneth Marek and John Seibyl
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 394;
Gilles Tamagnan
1Institute for Neurodegenerative Disorders, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Barret
1Institute for Neurodegenerative Disorders, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Alagille
1Institute for Neurodegenerative Disorders, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Terence Hamill
2Discovery Imaging, Merck Research Labs, West Point, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald Baldwin
1Institute for Neurodegenerative Disorders, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei Koren
1Institute for Neurodegenerative Disorders, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Russell
1Institute for Neurodegenerative Disorders, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danna Jennings
1Institute for Neurodegenerative Disorders, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Marek
1Institute for Neurodegenerative Disorders, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Seibyl
1Institute for Neurodegenerative Disorders, New Haven, CT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 52 no. supplement 1 394

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2011

Author Information

  1. Gilles Tamagnan1,
  2. Olivier Barret1,
  3. David Alagille1,
  4. Terence Hamill2,
  5. Ronald Baldwin1,
  6. Andrei Koren1,
  7. David Russell1,
  8. Danna Jennings1,
  9. Kenneth Marek1 and
  10. John Seibyl1
  1. 1Institute for Neurodegenerative Disorders, New Haven, CT
  2. 2Discovery Imaging, Merck Research Labs, West Point, PA

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014100
Feb 2015100
Mar 2015200
Jun 2015500
Jul 2015700
Sep 2015700
Oct 2015600
Nov 2015300
Dec 2015300
Jan 2016200
May 2016100
Jul 2016200
Aug 2016300
Oct 2016100
Nov 2016300
Dec 2016200
Feb 2017200
Mar 2017100
Apr 2017300
Jun 2017300
Jul 2017200
Aug 2017100
Jan 2018300
Feb 20181100
Mar 2018100
Apr 2018200
May 2018100
Jun 2018200
Jul 2018200
Aug 2018200
Sep 2018300
Oct 20181900
Nov 2018400
Dec 2018300
Jan 2019300
Feb 2019200
Mar 2019200
May 2019400
Jun 2019200
Aug 2019500
Sep 2019400
Oct 2019300
Jan 2020400
Feb 2020400
Mar 20201400
Apr 20201000
Jun 2020200
Jul 2020300
Aug 20201000
Sep 20202300
Oct 20201500
Nov 20201600
Dec 20201600
Jan 2021300
Feb 2021800
Mar 20211000
Apr 2021800
May 2021600
Jun 2021400
Jul 20211600
Aug 20213200
Sep 20211400
Oct 20211000
Nov 20217900
Dec 20214100
Jan 20226700
Feb 20222000
Mar 20221700
Apr 20225600
May 20222700
Jun 2022600
Jul 2022200
Aug 2022400
Sep 2022500
Oct 2022200
Nov 2022200
Dec 2022300
Jan 2023200
Mar 2023200
Apr 2023100
May 2023300
Jun 2023100
Jul 2023400
Aug 20232300
Sep 20231000
Oct 2023300
Nov 2023200
Dec 2023200
Jan 2024600
Feb 2024100
Mar 2024200
Apr 2024200
May 2024400
Jun 2024300
Jul 2024100
Aug 2024300
Sep 2024700
Oct 2024300
Nov 2024500
Dec 20241300
Jan 2025700
Feb 2025200
Mar 2025600
Apr 20251200
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First assessment of [18F]-FMH3 in human, a selective histamine H3 receptor PET tracer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
First assessment of [18F]-FMH3 in human, a selective histamine H3 receptor PET tracer
Gilles Tamagnan, Olivier Barret, David Alagille, Terence Hamill, Ronald Baldwin, Andrei Koren, David Russell, Danna Jennings, Kenneth Marek, John Seibyl
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 394;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First assessment of [18F]-FMH3 in human, a selective histamine H3 receptor PET tracer
Gilles Tamagnan, Olivier Barret, David Alagille, Terence Hamill, Ronald Baldwin, Andrei Koren, David Russell, Danna Jennings, Kenneth Marek, John Seibyl
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 394;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Basic Science

  • Neural correlates of opiate abuse differ in adolescent compared to adult animals
  • Cerebrocortical plasticity after acute and chronic unilateral lesion of the central vestibular system in rats: A Micro-PET study
  • Differential brain metabolism following single vs. repeated ethanol exposures in adolescent rat: A [18F]fluorodeoxyglucose-PET study
Show more Neurosciences: Basic Science

Basic Science I (Neuroscience): Tracer Characterization - Testing in vivo Properties of New and Recently Developed Radioligands

  • Evaluation of [18F]AZAN for quantification of nicotinic acetylcholine receptors in human brain
  • PET imaging of transporter mediated drug-drug interactions at the murine blood-brain barrier using [18F]-gefitinib
  • [11C]PHNO parametric imaging and test-retest study in humans using the HRRT scanner
Show more Basic Science I (Neuroscience): Tracer Characterization - Testing in vivo Properties of New and Recently Developed Radioligands

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire